How to Read a Certificate of Analysis (COA) for Peptides: Purity Testing Explained

When purchasing research peptides or seeking peptide therapy through compounding pharmacies and clinics, one document separates legitimate suppliers from questionable sources: the Certificate of Analysis (COA). Understanding how to properly read and verify a peptide COA is essential for ensuring you receive pure, correctly identified compounds that match what you're paying for.

This comprehensive guide breaks down every component of a peptide COA, explains the testing methodologies used, identifies red flags, and provides actionable steps for verifying authenticity. Whether you're a researcher, clinic administrator, or individual seeking peptide therapy, mastering COA interpretation is your first line of defense against contaminated, underdosed, or counterfeit products.

What Is a Certificate of Analysis?

A Certificate of Analysis is a document issued by an analytical testing laboratory that verifies the identity, purity, concentration, and composition of a peptide product. Legitimate peptide suppliers obtain COAs from third-party laboratories using validated analytical methods to confirm their products meet specified quality standards.

For peptide products, COAs typically include:

• Product identification (peptide name, sequence, batch/lot number)
• Purity percentage (typically measured by HPLC)
• Molecular weight confirmation (via mass spectrometry)
• Concentration/potency (mg per vial)
• Contamination testing (endotoxins, heavy metals, residual solvents)
• Laboratory information (name, date of analysis, analyst signature)
• Testing methodology (HPLC, MS, other analytical techniques)

Reputable suppliers provide batch-specific COAs—meaning each production lot receives independent testing. Generic or recycled COAs that don't match specific batch numbers are major red flags.

HPLC Purity Testing: The Gold Standard

High-Performance Liquid Chromatography (HPLC) represents the industry standard for peptide purity analysis. This analytical technique separates compounds in a mixture and quantifies the target peptide versus impurities.

Understanding HPLC Results

An HPLC analysis generates a chromatogram—a graph showing peaks that represent different compounds detected over time. For peptide COAs:

• Main peak: Represents the target peptide
• Retention time: How long the peptide takes to pass through the column (should be consistent batch-to-batch)
• Peak area percentage: Quantifies purity (the main peak area divided by total peak area)
• Minor peaks: Indicate impurities, degradation products, or related peptides

Legitimate peptide suppliers typically achieve 95-99% purity by HPLC. Research-grade peptides commonly show 98%+ purity, while pharmaceutical-grade products may exceed 99%.

HPLC Method Variations

Two primary HPLC methods are used for peptide analysis:

Reverse-Phase HPLC (RP-HPLC): Most common method; separates peptides based on hydrophobicity. Ideal for most synthetic peptides.

Ion-Exchange HPLC: Separates based on charge; useful for highly charged peptides or when RP-HPLC resolution is insufficient.

The COA should specify which HPLC method was used. Consistency in methodology across batches enables meaningful comparison.

Mass Spectrometry: Confirming Molecular Identity

While HPLC measures purity, mass spectrometry (MS) confirms molecular identity by measuring the exact mass-to-charge ratio of molecules. This verification ensures you're receiving the correct peptide, not a different compound with similar HPLC retention characteristics.

Key Mass Spectrometry Data Points

• Theoretical mass: The calculated molecular weight based on peptide sequence
• Observed mass: The actual measured mass from the sample
• Delta (Δ): Difference between theoretical and observed mass
• Acceptable range: Typically ±0.1-0.5 Daltons for electrospray ionization (ESI-MS)

For example, BPC-157 has a theoretical molecular weight of approximately 1419.5 Da. A legitimate COA should show an observed mass within 0.5 Da of this value.

Mass Spectrometry Methods

Common MS techniques for peptide verification include:

• ESI-MS (Electrospray Ionization): Most common; gentle ionization suitable for intact peptides
• MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight): Good for larger peptides and proteins
• LC-MS (Liquid Chromatography-Mass Spectrometry): Combines separation and identification in one analysis

High-quality COAs often include the full mass spectrum graph, allowing independent verification of the data.

Additional Quality Testing Parameters

Endotoxin Testing

Bacterial endotoxins are toxins from gram-negative bacteria that can contaminate peptide products during synthesis or handling. For injectable peptides, endotoxin testing is critical.

• Method: Limulus Amebocyte Lysate (LAL) test
• Acceptable limits: and guidelines implement rigorous COA verification:

• Source only from FDA-registered facilities or suppliers with comprehensive testing
• Verify COAs before accepting raw materials
• Maintain detailed records linking COAs to specific batches
• Conduct additional in-house testing when appropriate
• Refuse shipments with inadequate or suspicious documentation

When selecting a peptide therapy provider, ask about their supplier vetting process and COA verification procedures. Quality clinics and pharmacies will gladly discuss their quality assurance protocols.

COA Requirements by Provider Type

Research Peptide Suppliers

Research peptide vendors selling "for laboratory use only" products should provide:

• Batch-specific HPLC and MS data
• Purity ≥95% (98%+ preferred)
• Endotoxin testing for products marketed as injectable
• Clear batch/lot identification

Find verified suppliers with consistent COA documentation at our peptide brands directory.

Compounding Pharmacies

Pharmacies compounding prescription peptides must meet higher standards:

• Pharmaceutical-grade raw materials (≥99% purity)
• Complete impurity profiling
• Endotoxin testing <0.5 EU/mg
• Heavy metal and residual solvent testing
• Sterility testing for injectable preparations
• Stability data supporting beyond-use dating

Research Laboratories

Academic and commercial research labs typically require:

• Comprehensive characterization data
• Stability information for long-term storage
• Detailed impurity profiles
• Batch-to-batch consistency data
• Chain of custody documentation

Interpreting Purity Percentages

What Different Purity Levels Mean

• 90-95% purity: Acceptable for some research applications; may contain significant impurities
• 95-98% purity: Standard for research-grade peptides; suitable for most laboratory work
• 98-99% purity: High-quality research grade; preferred for animal studies
• ≥99% purity: Pharmaceutical grade; required for human clinical applications

Purity requirements depend on intended use. For peptide therapy through licensed providers, always insist on pharmaceutical-grade (≥99%) products.

Understanding Impurity Composition

The 1-5% impurities in research-grade peptides typically consist of:

• Related peptides: Sequences with amino acid deletions, additions, or substitutions
• Truncated sequences: Incomplete peptides from synthesis
• Degradation products: From hydrolysis or oxidation
• Residual protecting groups: From incomplete deprotection during synthesis
• Salts and counterions: TFA, acetate, or chloride counterions

Advanced COAs include detailed impurity profiling identifying specific contaminants.

Storage and Stability Considerations

Some comprehensive COAs include stability data:

• Recommended storage conditions: Temperature, light exposure, humidity
• Stability testing results: Purity over time under specified conditions
• Reconstitution stability: How long reconstituted peptides remain stable
• Freeze-thaw stability: Effects of temperature cycling

This information guides proper handling and storage to maintain peptide integrity from receipt through use.

Special Considerations for Specific Peptides

GLP-1 Receptor Agonists (Semaglutide, Tirzepatide)

These complex peptides require additional characterization:

• Purity typically ≥97% by HPLC
• Specific impurity limits for related peptides
• High-resolution mass spectrometry for sequence confirmation
• Potency testing (biological activity assays)
• Aggregation testing (important for long-term stability)

Copper Peptides (GHK-Cu)

Copper-containing peptides need:

• Copper content verification (should match stoichiometric ratio)
• Metal impurity testing beyond standard heavy metals
• Stability data (copper peptides can degrade faster)
• pH verification (affects stability and activity)

Lyophilized vs. Liquid Formulations

COA requirements differ:

Lyophilized (freeze-dried) peptides:

• Moisture content analysis
• Residual solvent testing
• Reconstitution verification
• Excipient identification

Liquid formulations:

• pH measurement
• Osmolality
• Preservative content (if applicable)
• Particulate matter testing
• Sterility testing

Regulatory Perspectives

FDA Position

The FDA does not pre-approve research peptides sold as "not for human consumption," but compounded peptide medications must meet pharmaceutical standards:

• Source materials from FDA-registered facilities when possible
• Follow USP compounding standards
• Maintain complete documentation including COAs
• Implement quality assurance programs

Under 2026 regulations, increased scrutiny applies to peptide compounding, making robust COA documentation more critical than ever.

Canadian Regulations

Health Canada requires:

• Natural Product Numbers (NPNs) for certain peptide products marketed as supplements
• GMP compliance for manufacturers
• Proper licensing for compounding pharmacies
• Complete quality documentation for imported peptides

Practical Steps for Consumers

If you're considering peptide therapy:

1. Ask your provider about source verification: Quality clinics will explain their supplier vetting process
2. Request to see COAs: Legitimate providers won't hesitate to share quality documentation
3. Verify the laboratory: Independently confirm the testing lab exists and is accredited
4. Check batch matching: Ensure the COA batch number matches your product
5. Look for comprehensive testing: Purity alone isn't enough; endotoxins and identity confirmation matter
6. Be wary of unusually low prices: Quality testing is expensive; suspiciously cheap peptides likely lack proper verification

Explore our blog for additional guidance on evaluating peptide suppliers and understanding quality standards.

Key Takeaways

• Certificates of Analysis verify peptide identity, purity, and safety through third-party laboratory testing
• HPLC purity testing (≥95%) and mass spectrometry molecular weight confirmation are essential minimum requirements
• Batch-specific COAs with complete laboratory identification are non-negotiable for legitimate products
• Red flags include missing information, perfect results, unverifiable laboratories, and generic documentation
• Always verify COAs by contacting the issuing laboratory directly
• Different applications require different purity levels: research use (≥95%), pharmaceutical use (≥99%)
• Compounding pharmacies and clinics should maintain rigorous COA verification protocols
• Additional testing for endotoxins, heavy metals, and residual solvents is critical for injectable peptides
• When in doubt, request independent third-party testing of your peptide product
• Quality documentation protects both providers and patients from contaminated or counterfeit products

This content is for educational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any peptide protocol.